Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Ipatasertib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT3 known ✓ | Q9Y243 | 20/20 | 0.98 |
| ▸ | AKT1 known ✓ | P31749 | 19/20 | 0.98 |
| ▸ | AKT2 known ✓ | P31751 | 19/20 | 0.98 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.98 |
| ▸ | PRKG1 | Q13976 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ipatasertib SCHEMBL21900357 | 1.00 | AKT3 (0.98) | AKT3AKT1AKT2PIK3CAPRKG1 | |
| Ipatasertib SCHEMBL29393010 | 1.00 | AKT3 (0.98) | AKT3AKT1AKT2PIK3CAPRKG1 | |
| Ipatasertib SCHEMBL15390324 | 1.00 | AKT3 (0.98) | AKT3AKT1AKT2PIK3CAPRKG1 | |
| Ipatasertib SCHEMBL192342 | 1.00 | AKT3 (0.98) | AKT3AKT1AKT2PIK3CAPRKG1 | |
| Ipatasertib SCHEMBL29409453 | 1.00 | AKT3 (0.98) | AKT3AKT1AKT2PIK3CAPRKG1 | |
| Ipatasertib SCHEMBL191805 | 1.00 | AKT3 (0.98) | AKT3AKT1AKT2PIK3CAPRKG1 | |
| Ipatasertib SCHEMBL15390761 | 1.00 | AKT3 (0.98) | AKT3AKT1AKT2PIK3CAPRKG1 | |
| Ipatasertib SCHEMBL1740213 | 1.00 | AKT3 (0.98) | AKT3AKT1AKT2PIK3CAPRKG1 | |
| Ipatasertib SCHEMBL19867534 | 0.99 | AKT3 (1.00) | AKT3AKT1AKT2PIK3CAPRKG1 | |
| Ipatasertib SCHEMBL191492 | 0.99 | AKT3 (1.00) | AKT3AKT1AKT2PIK3CAPRKG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2858989-B1 | AMORPHOUS FORM OF AN AKT INHIBITING PYRIMIDINYL-CYCLOPENTANE COMPOUND, COMPOSITIONS AND METHODS THEREOF | GENENTECH INC (US) | 2020-05-06 | — | — | EP | claimed |
| EP-4282973-A2 | PROCESSES FOR THE PREPARATION OF PYRIMIDINYLCYCLOPENTANE COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2023-11-29 | — | — | EP | disclosed |
| EP-3656764-B1 | PROCESSES FOR THE PREPARATION OF PYRIMIDINYLCYCLOPENTANE COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2023-07-05 | — | — | EP | disclosed |